Pharmacokinetics of Milbemycin Oxime in Pekingese Dogs after Single Oral and Intravenous Administration
Veterinary Medicine and Science · 2025
DOI: 10.1002/vms3.70312 ↗Kurz gefasst
Fachartikel in der Zeitschrift Veterinary Medicine and Science, 2025. Verfasst von Ze-En Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Animal Science and Technology, Henan University of Science and Technology, Luoyang, China. Hauptthemen laut MEDLINE: Macrolides, Anti-Bacterial Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Postgraduate Education Reform and Quality Improvement Project of Henan Province.
Abstract (Originalsprache)
Objective
This study aimed to characterize the pharmacokinetic profiles of milbemycin oxime in Pekingese dogs following a single oral (PO) and intravenous (IV) dose. Six clinically healthy Pekingese dogs, with an average body weight (BW) of 4.75 kg, were included. Each dog received an IV injection of milbemycin oxime solution and PO doses of both milbemycin oxime tablets and nanoemulsion, all administered at 1 mg/kg BW.
Methods
Blood samples (∼0.6 mL) were collected at various time points, and milbemycin oxime concentrations were measured using a validated high‐performance liquid chromatography (HPLC) method with ultraviolet (UV) detection. Pharmacokinetic parameters were obtained through non‐compartmental analysis (NCA) using WinNonLin software.
Results
Oral administration of milbemycin oxime tablets resulted in a peak concentration ( C max ) of 0.33 ± 0.07 µg/mL at 2.47 ± 1.90 h, with a mean residence time (MRT) of 21.96 ± 14.43 h and an absolute bioavailability of 51.44% ± 21.76%. In contrast, the nanoemulsion achieved a significantly higher C max of 8.87 ± 1.88 µg/mL, with a much quicker time to peak concentration ( T max ) at 0.33 ± 0.13 h, an MRT of 21.74 ± 18.21 h, and an absolute bioavailability of 99.26% ± 12.14%. After IV administration, total clearance (Cl) and steady‐state volume of distribution ( V SS ) were 0.13 ± 0.06 mL/kg/h and 2.36 ± 0.73 mL/kg, respectively.
Conclusions
These findings demonstrate that the milbemycin oxime nanoemulsion is absorbed more rapidly and completely, with significantly higher bioavailability than the tablet form. This suggests that the nanoemulsion could effectively overcome the issues of poor diffusion and low bioavailability associated with tablet formulations, positioning it as a promising alternative to traditional milbemycin oxime tablets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Animal Science and Technology, Henan University of Science and Technology, Luoyang, China.
ORCID-Profile: Ze-En Li
Förderung
- Postgraduate Education Reform and Quality Improvement Project of Henan Province
Zitieren
APA
Li, Z. E., Duan, M. H., Dai, Y., Jin, Y. G., Liu, Y., Zhang, Y. N., Li, X. P., & Yang, F. (2025). Pharmacokinetics of Milbemycin Oxime in Pekingese Dogs after Single Oral and Intravenous Administration. Veterinary Medicine and Science. https://doi.org/10.1002/vms3.70312
Vancouver
Li ZE, Duan MH, Dai Y, Jin YG, Liu Y, Zhang YN, et al. Pharmacokinetics of Milbemycin Oxime in Pekingese Dogs after Single Oral and Intravenous Administration. Veterinary Medicine and Science. 2025. doi:10.1002/vms3.70312
BibTeX
@article{Li2025,
author = {Li, Ze-En and Duan, Ming-Hui and Dai, Yan and Jin, Yang-Guang and Liu, Yue and Zhang, Yan-Ni and Li, Xing-Ping and Yang, Fan},
title = {Pharmacokinetics of Milbemycin Oxime in Pekingese Dogs after Single Oral and Intravenous Administration},
journal = {Veterinary Medicine and Science},
year = {2025},
doi = {10.1002/vms3.70312}
}
EUVIMED